Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Dexamethasone Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Antineoplastic Agents Medicine & Life Sciences
Drug Administration Schedule Medicine & Life Sciences
Serum Sickness Medicine & Life Sciences
Drug Hypersensitivity Medicine & Life Sciences
Oligopeptides Medicine & Life Sciences
Thalidomide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2008

Research Output 2003 2014

  • 367 Citations
  • 4 h-Index
  • 2 Article
  • 2 Letter
19 Citations

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

Dytfeld, D., Jasielec, J., Griffith, K. A., Lebovic, D., Vesole, D. H., Jagannath, S., Al-Zoubi, A., Anderson, T., Detweiler-Short, K., Stockerl-Goldstein, K., Ahmed, A., Jobkar, T., Durecki, D. E., McDonnell, K., Mietzel, M., Couriel, D., Kaminski, M., Vij, R. & Jakubowiak, A. J. Sep 1 2014 In : Haematologica. 99, 9

Research output: Contribution to journalLetter

Drug Administration Schedule
Oligopeptides
Thalidomide
Survival Analysis
Multiple Myeloma
229 Citations

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

Jakubowiak, A. J., Dytfeld, D., Griffith, K. A., Lebovic, D., Vesole, D. H., Jagannath, S., Al-Zoubi, A., Anderson, T., Nordgren, B., Detweiler-Short, K., Stockerl-Goldstein, K., Ahmed, A., Jobkar, T., Durecki, D. E., McDonnell, K., Mietzel, M., Couriel, D., Kaminski, M. & Vij, R. Aug 30 2012 In : Blood. 120, 9, p. 1801-1809 9 p.

Research output: Contribution to journalArticle

Stem cells
Multiple Myeloma
Dexamethasone
Transplantation
Toxicity
63 Citations

Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma

Jakubowiak, A. J., Kendall, T., Al-Zoubi, A., Khaled, Y., Mineishi, S., Ahmed, A., Campagnaro, E., Brozo, C., Braun, T., Talpaz, M. & Kaminski, M. S. Oct 20 2009 In : Journal of Clinical Oncology. 27, 30, p. 5015-5022 8 p.

Research output: Contribution to journalArticle

Dexamethasone
Stem Cell Transplantation
Disease-Free Survival
Multiple Myeloma
Therapeutics
56 Citations

Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment [2]

Hellerstedt, B. & Ahmed, A. Dec 2003 In : Annals of Oncology. 14, 12, p. 1792 1 p.

Research output: Contribution to journalLetter

Serum Sickness
Drug Hypersensitivity
Pregnancy Complications
Delayed Hypersensitivity
Systemic Lupus Erythematosus